US Stock MarketDetailed Quotes

MEDS Trxade Health

Watchlist

18.4200
0.00000.00%

Close Jul 11 16:00 ET

18.4000
-0.0200-0.11%

Pre 09:14 ET

25.90MMarket Cap1.79P/E (TTM)

Trxade Health Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-611.24%-9.66M

-700.13%-1.59M

-150.69%-980.24K

-188.48%-40.85K

166.81%787.25K

-35.75%-1.36M

92.24%-199.02K

553.20%1.93M

106.26%46.17K

-70.49%-1.18M

Net income from continuing operations

-483.91%-6.64M

-470.87%-13.72M

-2,691.52%-11.72M

587.04%648.25K

-36.32%-1.52M

-17.68%-1.14M

54.79%-2.4M

46.49%-419.7K

107.25%94.35K

56.86%-1.11M

Operating gains losses

68.12%24.27K

-61.36%29.74K

-72.40%3.76K

-78.71%3.76K

-47.39%7.78K

-53.26%14.43K

-63.16%76.96K

437.90%13.62K

101.54%17.66K

-98.85%14.79K

Depreciation and amortization

-84.13%8.3K

439.19%1.05M

366.12%715.45K

434.66%228.54K

4.52%53.52K

-10.26%52.32K

40.17%194.7K

323.73%153.49K

-294.91%-68.29K

49.63%51.21K

Change In working capital

-2,245.85%-7.51M

2,098.01%5.66M

805.80%4.71M

-1,471.32%-953.48K

5,150.08%2.23M

-103.22%-320.11K

-76.25%257.58K

-52.35%519.87K

71.90%-60.68K

-109.26%-44.09K

-Change in receivables

-14,912.47%-7.82M

-8.59%-548.71K

-336.21%-336.42K

75.44%-173.53K

-175.03%-91.52K

183.43%52.76K

-269.52%-505.32K

-87.20%142.42K

-434.09%-706.49K

-72.85%121.98K

-Change in inventory

33.99%-4.4K

8,281.66%4.23M

13,422.40%4.27M

-99.71%2.66K

95.19%-35.01K

96.93%-6.67K

-106.27%-51.74K

90.51%-32.07K

1,991.68%926.51K

-320.09%-728.51K

-Change in prepaid assets

-490.45%-135.01K

-88.55%38.37K

29.08%176.82K

-246.49%-166.76K

-80.92%51.17K

87.57%-22.87K

423.22%335.07K

-24.25%136.98K

281.51%113.84K

216.70%268.27K

-Change in payables and accrued expense

43.28%-214.25K

17,099.55%2.02M

1,212.51%1.12M

262.65%936.83K

113.50%338.8K

-174.66%-377.73K

-105.75%-11.86K

-210.27%-100.53K

-1,355.48%-575.99K

146.64%158.69K

-Change in other current assets

----

--306.53K

216.23%154.41K

----

--0

---132.85K

----

-Change in other current liabilities

1,817.49%659.58K

-178.09%-383.78K

-233.67%-676.26K

-3,607.75%-1.7M

15,490.28%1.96M

168.36%34.4K

474.70%491.43K

1,579.30%505.91K

310.17%48.6K

69.86%-12.75K

Cash from discontinued investing activities

-223.39%-526.94K

64.77%-481.18K

115.18%112.72K

-562.26K

-458.68K

26,624.91%427.05K

-1.37M

-742.55K

Operating cash flow

-993.86%-10.19M

-32.53%-2.07M

-172.82%-867.52K

-4.54%-603.11K

127.89%328.57K

6.92%-931.53K

39.03%-1.56M

379.18%1.19M

21.84%-576.93K

-70.49%-1.18M

Investing cash flow

Cash flow from continuing investing activities

-2,771.19%-2.5M

-46,088.52%-344.45K

-211.59%-350K

359.14%144.42K

81.51%-51.8K

-478.57%-87.07K

103.31%749

1,488.08%313.65K

-55.73K

-280.17K

Capital expenditure reported

----

--0

349.19%138.88K

----

--0

--335.9K

---55.73K

---280.17K

Net PPE purchase and sale

----

--0

----

103.31%749

1.53%-22.25K

--0

Net business purchase and sale

----

---344.45K

---350K

----

--0

----

Net investment purchase and sale

-2,771.19%-2.5M

----

---87.07K

----

Cash from discontinued investing activities

Investing cash flow

8,133.14%27.43M

35.56%-275.72K

-204.50%-350K

-271.63%-207.11K

81.51%-51.8K

1,348.68%333.2K

-1,793.45%-427.85K

-408.69%-114.94K

---55.73K

---280.17K

Financing cash flow

Cash flow from continuing financing activities

-2,139.03%-13.89M

694.87%1.91M

4,837.30%1.34M

7,926.88%614.96K

-231.87%-725.28K

348.52%681.26K

215.20%239.83K

-28.19K

96.26%-7.86K

30,103.19%550K

Net issuance payments of debt

----

--250K

--25K

----

--0

----

Net common stock issuance

----

--0

----

--130.92K

----

Cash dividends paid

---12.67M

----

--0

----

Proceeds from stock option exercised by employees

377,142.86%26.41K

85.37%1.62K

--0

--1.62K

-99.20%7

-94.80%875

--0

Net other financing activities

-282.95%-1.25M

1,431.63%1.65M

923.60%1.31M

5,063.19%389.96K

---726.9K

--681.25K

--108.04K

---159.11K

---7.86K

----

Cash from discontinued financing activities

-5K

-81.82%-500K

-275K

Financing cash flow

-2,139.76%-13.9M

4,098.56%1.41M

540.45%1.34M

1,563.13%114.96K

-231.87%-725.28K

348.52%681.26K

83.11%-35.17K

---303.19K

96.26%-7.86K

30,103.19%550K

Net cash flow

Beginning cash position

-86.33%151.91K

-64.94%1.09M

-89.42%34.03K

-22.52%745.56K

-36.17%1.19M

-64.42%1.11M

-47.25%3.12M

-90.99%321.72K

-78.71%962.23K

-64.09%1.87M

Current changes in cash

3,936.16%3.35M

53.49%-942.99K

-84.75%117.87K

-8.55%-695.27K

50.63%-448.52K

106.62%82.92K

27.51%-2.03M

272.08%773.18K

32.44%-640.51K

-31.79%-908.46K

End cash Position

193.01%3.5M

-86.13%151.91K

-89.42%34.03K

-22.52%745.56K

-36.17%1.19M

-64.94%1.09M

-90.99%321.72K

-78.71%962.23K

Free cash flow

-993.86%-10.19M

-32.53%-2.07M

-156.80%-867.52K

26.62%-464.24K

113.01%189.69K

6.92%-931.53K

39.56%-1.56M

439.90%1.53M

14.29%-632.66K

-111.03%-1.46M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-611.24%-9.66M	-700.13%-1.59M	-150.69%-980.24K	-188.48%-40.85K	166.81%787.25K	-35.75%-1.36M	92.24%-199.02K	553.20%1.93M	106.26%46.17K	-70.49%-1.18M
Net income from continuing operations	-483.91%-6.64M	-470.87%-13.72M	-2,691.52%-11.72M	587.04%648.25K	-36.32%-1.52M	-17.68%-1.14M	54.79%-2.4M	46.49%-419.7K	107.25%94.35K	56.86%-1.11M
Operating gains losses	68.12%24.27K	-61.36%29.74K	-72.40%3.76K	-78.71%3.76K	-47.39%7.78K	-53.26%14.43K	-63.16%76.96K	437.90%13.62K	101.54%17.66K	-98.85%14.79K
Depreciation and amortization	-84.13%8.3K	439.19%1.05M	366.12%715.45K	434.66%228.54K	4.52%53.52K	-10.26%52.32K	40.17%194.7K	323.73%153.49K	-294.91%-68.29K	49.63%51.21K
Change In working capital	-2,245.85%-7.51M	2,098.01%5.66M	805.80%4.71M	-1,471.32%-953.48K	5,150.08%2.23M	-103.22%-320.11K	-76.25%257.58K	-52.35%519.87K	71.90%-60.68K	-109.26%-44.09K
-Change in receivables	-14,912.47%-7.82M	-8.59%-548.71K	-336.21%-336.42K	75.44%-173.53K	-175.03%-91.52K	183.43%52.76K	-269.52%-505.32K	-87.20%142.42K	-434.09%-706.49K	-72.85%121.98K
-Change in inventory	33.99%-4.4K	8,281.66%4.23M	13,422.40%4.27M	-99.71%2.66K	95.19%-35.01K	96.93%-6.67K	-106.27%-51.74K	90.51%-32.07K	1,991.68%926.51K	-320.09%-728.51K
-Change in prepaid assets	-490.45%-135.01K	-88.55%38.37K	29.08%176.82K	-246.49%-166.76K	-80.92%51.17K	87.57%-22.87K	423.22%335.07K	-24.25%136.98K	281.51%113.84K	216.70%268.27K
-Change in payables and accrued expense	43.28%-214.25K	17,099.55%2.02M	1,212.51%1.12M	262.65%936.83K	113.50%338.8K	-174.66%-377.73K	-105.75%-11.86K	-210.27%-100.53K	-1,355.48%-575.99K	146.64%158.69K
-Change in other current assets	----	--306.53K	216.23%154.41K	----	----	----	--0	---132.85K	----	----
-Change in other current liabilities	1,817.49%659.58K	-178.09%-383.78K	-233.67%-676.26K	-3,607.75%-1.7M	15,490.28%1.96M	168.36%34.4K	474.70%491.43K	1,579.30%505.91K	310.17%48.6K	69.86%-12.75K
Cash from discontinued investing activities	-223.39%-526.94K	64.77%-481.18K	115.18%112.72K	-562.26K	-458.68K	26,624.91%427.05K	-1.37M	-742.55K
Operating cash flow	-993.86%-10.19M	-32.53%-2.07M	-172.82%-867.52K	-4.54%-603.11K	127.89%328.57K	6.92%-931.53K	39.03%-1.56M	379.18%1.19M	21.84%-576.93K	-70.49%-1.18M
Investing cash flow
Cash flow from continuing investing activities	-2,771.19%-2.5M	-46,088.52%-344.45K	-211.59%-350K	359.14%144.42K	81.51%-51.8K	-478.57%-87.07K	103.31%749	1,488.08%313.65K	-55.73K	-280.17K
Capital expenditure reported	----	--0	--0	349.19%138.88K	----	----	--0	--335.9K	---55.73K	---280.17K
Net PPE purchase and sale	----	--0	--0	--0	----	----	103.31%749	1.53%-22.25K	--0	--0
Net business purchase and sale	----	---344.45K	---350K	----	----	----	--0	--0	----	----
Net investment purchase and sale	-2,771.19%-2.5M	----	----	----	----	---87.07K	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	8,133.14%27.43M	35.56%-275.72K	-204.50%-350K	-271.63%-207.11K	81.51%-51.8K	1,348.68%333.2K	-1,793.45%-427.85K	-408.69%-114.94K	---55.73K	---280.17K
Financing cash flow
Cash flow from continuing financing activities	-2,139.03%-13.89M	694.87%1.91M	4,837.30%1.34M	7,926.88%614.96K	-231.87%-725.28K	348.52%681.26K	215.20%239.83K	-28.19K	96.26%-7.86K	30,103.19%550K
Net issuance payments of debt	----	--250K	--25K	----	----	----	--0	--0	----	----
Net common stock issuance	----	--0	----	----	----	----	--130.92K	----	----	----
Cash dividends paid	---12.67M	----	----	----	----	--0	----	----	----	----
Proceeds from stock option exercised by employees	377,142.86%26.41K	85.37%1.62K	--0	--0	--1.62K	-99.20%7	-94.80%875	--0	--0	--0
Net other financing activities	-282.95%-1.25M	1,431.63%1.65M	923.60%1.31M	5,063.19%389.96K	---726.9K	--681.25K	--108.04K	---159.11K	---7.86K	----
Cash from discontinued financing activities	-5K	-81.82%-500K	0			0	-275K	-275K
Financing cash flow	-2,139.76%-13.9M	4,098.56%1.41M	540.45%1.34M	1,563.13%114.96K	-231.87%-725.28K	348.52%681.26K	83.11%-35.17K	---303.19K	96.26%-7.86K	30,103.19%550K
Net cash flow
Beginning cash position	-86.33%151.91K	-64.94%1.09M	-89.42%34.03K	-22.52%745.56K	-36.17%1.19M	-64.42%1.11M	-47.25%3.12M	-90.99%321.72K	-78.71%962.23K	-64.09%1.87M
Current changes in cash	3,936.16%3.35M	53.49%-942.99K	-84.75%117.87K	-8.55%-695.27K	50.63%-448.52K	106.62%82.92K	27.51%-2.03M	272.08%773.18K	32.44%-640.51K	-31.79%-908.46K
End cash Position	193.01%3.5M	-86.13%151.91K	-86.13%151.91K	-89.42%34.03K	-22.52%745.56K	-36.17%1.19M	-64.94%1.09M	-64.94%1.09M	-90.99%321.72K	-78.71%962.23K
Free cash flow	-993.86%-10.19M	-32.53%-2.07M	-156.80%-867.52K	26.62%-464.24K	113.01%189.69K	6.92%-931.53K	39.56%-1.56M	439.90%1.53M	14.29%-632.66K	-111.03%-1.46M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall